focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 13.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

1 Jun 2017 18:25

RNS Number : 9354G
CATCo Reinsurance Opps Fund Ltd
01 June 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Catco Reinsurance Opportunities Fund Limited

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

Type 1 Disclosure as per the Transparency Directive II Regulation

ü

3. Full name of person(s) subject to thenotification obligation: iii

Schroders plc

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

31.05.17

6. Date on which issuer notified:

01.06.17

7. Threshold(s) that is/are crossed orreached: vi, vii

Below 10%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

Ordinary

 

BMG1961Q2095

 

 

 

35,837,284

 

 

35,837,284

 

 

36,508,062

 

 

N/A

 

 

36,508,062

 

 

N/A

 

 

 

9.321%

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

36,508,062

9.321%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Schroder & Co. Limited 26,338,318 6.725%

Schroders (C.I.) Limited 8,860,582 2.262%

Schroder Investment Management Limited 1,309,162 0.334%

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

The shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements. This disclosure has been calculated based on issue share capital amount 391,666,424.

 

14. Contact name:

 

Judith Wynne

15. Contact telephone number:

 

+441 493 9005

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUAUBRBAANRAR
Date   Source Headline
24th May 20064:36 pmRNSRule 8.3- Cambrdige Antibody
24th May 20064:24 pmRNSEPT Disclosure
24th May 20063:55 pmRNSRule 8.3- Cambridge Antibody
24th May 20063:35 pmRNSHolding(s) in Company
24th May 20063:20 pmRNSHolding(s) in Company
24th May 20061:40 pmRNSHolding(s) in Company
24th May 200612:16 pmRNSEPT Disclosure
24th May 200611:46 amRNSEPT Disclosure
24th May 200610:11 amRNSRule 8.3- Cambridge Antibody
24th May 20067:02 amRNSRule 8.1- Cambridge Antibody
23rd May 20066:07 pmRNSMarket Maker Holding
23rd May 20065:01 pmRNSEPT Disclosure
23rd May 20064:29 pmRNSRule 8.3- Cambridge Antibody
23rd May 20063:35 pmRNSRule 8.3- Cambridge Antibody
23rd May 20063:17 pmRNSRule 8.3- Cambridge Antibody
23rd May 200611:46 amRNSEPT Disclosure
23rd May 200611:46 amRNSRule 8.3- Cambridge Antibody
23rd May 200611:42 amRNSEPT Disclosure
23rd May 20067:01 amRNSAstraZeneca Offer for CAT
22nd May 20062:40 pmRNSRule 8.3- Cambridge Antibody
22nd May 20062:37 pmRNSRule 8.3- Cambridge Antibody
22nd May 200612:31 pmRNSEPT Disclosure
22nd May 200611:52 amRNSEPT Disclosure
22nd May 200611:41 amRNSEPT Disclosure
22nd May 20067:01 amRNSInterim Results
19th May 20065:41 pmRNSRule 8.3- Cambridge Antibody
19th May 20064:46 pmRNSEPT Disclosure
19th May 200612:49 pmRNSEPT Disclosure
19th May 200612:16 pmRNSEPT Disclosure
18th May 20065:08 pmRNSEPT Disclosure - Amendment
18th May 20065:05 pmRNSHolding(s) in Company
18th May 20064:28 pmRNSHolding(s) in Company
18th May 20064:27 pmRNSHolding(s) in Company
18th May 20064:25 pmRNSHolding(s) in Company
18th May 20064:00 pmRNSEPT Disclosure
18th May 20063:03 pmRNSRule 8.3- Cambridge Antibody
18th May 200611:44 amRNSEPT Disclosure
18th May 200611:21 amRNSNotice of Results
18th May 200611:08 amRNSEPT Disclosure
18th May 200610:54 amRNSHolding(s) in Company
18th May 20067:00 amRNSMarket Maker Holding
17th May 20063:46 pmRNSRule 8.3- Cambridge Antibody
17th May 20062:55 pmRNSEPT Disclosure - Amendment
17th May 200612:31 pmRNSEPT Disclosure
17th May 200612:28 pmRNSEPT Disclosure
17th May 200611:20 amRNSEPT Disclosure
17th May 200611:00 amRNSMerger Update
17th May 200610:31 amRNSRule 8.3- Cambridge Antibody
16th May 200612:41 pmRNSEPT Disclosure
16th May 200612:17 pmRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.